Check out the companies that make headlines before the bell. Charter Communication – Cable stock rose 7% after charters agreed to fuse with rival Cox Communication. The Total Company will change its name to Cox Communications within a year. Constellation Brands – The shares won 3.4% after Berkshire Hathaway doubled its shares in the beer importer. Warren Buffett’s position is currently worth around $2.2 billion. Applied Materials – Semiconductor manufacturers reduced their second quarter revenue by 5% after reporting $71 billion. The $5.26 billion semiconductor revenue disappointed what the $5.31 billion analyst was looking for. Take-Two Interactive Software – Shares fell 1.3% after video game companies issued weaker than expected guidance for full-year bookings. The company expects the figure to be between $5.9 billion and $6 billion, lacking a StreetAccount consensus of $7.82 billion. In the current quarter, we forecast two reservations between $1.25 billion and $100 billion, while analysts were supplying pencils at $1.28 billion. CAVA – The company said it expects sales growth for the same restaurant to ease over the year. Cava reported 10.8% sales growth in the first quarter at comparable locations, but maintained its full-year forecast of 6% to 8% improvement in that category. The decline occurred despite 22 cents’ first quarter earnings per share exceeding the analyst’s estimate of 14 cents, according to LSEG. The stocks had little change. Doxixity – The shares fell 19% after the healthcare platform issued disappointing guidance. Doximity expects the first quarter adjusted EBITDA ranges from $71 to $72 million per StreetAccount, more than the $74 million consensus estimate. Both the first quarter and full year revenue guidance also did not meet expectations. Vistra Corp – Independent power plant stocks jumped over 5% after purchasing seven natural gas facilities for $700 million from Lotus Infrastructure Partners. The gas plants are located in the PJM markets in New England, New York and California. Novo Nordisk – Pharmaceutical inventory slipped 5% after CEO Lars Fruergaard Jørgensen announced he would step down from his position, citing recent market challenges. Jorgensen remains in his position “to support a smooth transition to new leadership for a period of time” as Novo Nordisk searches for alternatives. – Reported by CNBC’s Michelle Fox, Spencer Kimball and Jesse Pound.
